Use of radioiodine in the management of hyperthyroidism in the UK: Development of guidelines

Thyroid

Volumn 7, Issue 2, 1997, Pages 229-231

  Lazarus, John H ^a   Clarke, S ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; RADIOACTIVE IODINE;

HUMAN; HYPERTHYROIDISM; MEDICAL DECISION MAKING; MEDICAL PRACTICE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 0030891221     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1997.7.229     Document Type: Review

References (14)

1. Glinoer D, Hesch D, Lagasse R, Laurberg P 1987 The management of hyperthyroidism due to Graves' disease in Europe in 1986: Results of an international survey. Acta Endocrinol 115(Suppl 285):1-23.
2. Hennemann G, Krenning EP, Sankaranarayanan K 1987 Place of radioactive iodine in treatment of thyrotoxicosis. Lancet 1:1369-1371.
3. Bierwaltes WH 1990 Treatment of hyperthyroidism with I-131. In: Falk SA (ed) Thyroid disease: Endocrinology, surgery, nuclear medicine, and radiotherapy. Raven Press, New York, pp 233-240.
4. Wartofsky L, Glinoer D, Solomon B, et al. 1991 Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan and the United States. Thyroid 1:129-135.
5. McDougall IR 1992 Thyroid diseases in clinical practice. Chapman & Hall Medical, London, pp 105-113.
6. Baxter M, Stewart PM, Daykin J, et al. 1993 Radioiodine therapy in young patients: Perception of risk and use. Q J Med 86:495-499.
7. Franklyn JA 1994 The management of hyperthyroidism. N Engl J Med 330:1731-1738.
8. Hedley AJ, Lazarus JH, McGhee SM, Jones RB, et al. 1992 Treatment of hyperthyroidism by radioactive iodine (Summary of a UK national survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes). J Roy Coll Physicians London 26:348-351.
9. European Association of Nuclear Medicine Task Group on Radionuclide Therapy. 1993 Radionuclide therapy: From palliative to cure.
10. European Thyroid Association 1995 Report of European Thyroid Association's Committee on Radioiodine Therapy in Thyrotoxicosis. I-131 therapy for thyrotoxicosis. Mallinckredt Medical, Belgium, p 8.
11. Hardisty CA, Jones SJ, Hedley AJ, et al. 1990 Clinical outcome and costs of care in radioiodine treatment of hyperthyroidism. J R Coll Physicians London 24:36-42.
12. 1993 Radioiodine for the treatment of thyroid disease. Drug Ther Bull 31:39-40.
13. McGhee SM, McInnes GT, Hedley AJ, et al. 1994 Coordinating and standardising long-term care: Evaluation of the West of Scotland shared-care scheme for hypertension. Br J Gen Pract 44:441-445.
14. Royal College of Physicians 1995 Guidelines for the use of radioiodine in the management of hyperthyroidism: A summary. [Prepared by the Radioiodine Audit Subcommittee of the Royal College of Physicians Committee on Diabetes and Endocrinology and the Research Unit of the Royal College of Physicians.] J R Coll Physicians London 29(no. 6:464-469.*